Terms: = Ovarian cancer AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A
133 results:
1. Period Analysis of Intraracial Differences in Incidence and Survival Rates in Epithelial ovarian cancer.
Han L; Husaiyin S; Liu J; Maimaiti M; Niyazi M; Li L
Comput Math Methods Med; 2021; 2021():8032209. PubMed ID: 34925544
[TBL] [Abstract] [Full Text] [Related]
2. RNA-binding protein FXR1 drives cMYC translation by recruiting eif4f complex to the translation start site.
George J; Li Y; Kadamberi IP; Parashar D; Tsaih SW; Gupta P; Geethadevi A; Chen C; Ghosh C; Sun Y; Mittal S; Ramchandran R; Rui H; Lopez-Berestein G; Rodriguez-Aguayo C; Leone G; Rader JS; Sood AK; Dey M; Pradeep S; Chaluvally-Raghavan P
Cell Rep; 2021 Nov; 37(5):109934. PubMed ID: 34731628
[TBL] [Abstract] [Full Text] [Related]
3. KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma.
Saglam O; Tang Z; Tang G; Medeiros LJ; Toruner GA
PLoS One; 2020; 15(9):e0238477. PubMed ID: 32877461
[TBL] [Abstract] [Full Text] [Related]
4. Functional recovery in older women undergoing surgery for gynaecological malignancies: A systematic review and narrative synthesis.
Martin FE; Kalsi T; Baker H; Bharathan R; Sbai M; Partridge JSL; Dhesi JK
J Geriatr Oncol; 2020 Sep; 11(7):1087-1095. PubMed ID: 32601003
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA SDHAP1 confers paclitaxel resistance of ovarian cancer by regulating EIF4G2 expression via miR-4465.
Zhao H; Wang A; Zhang Z
J Biochem; 2020 Aug; 168(2):171-181. PubMed ID: 32211849
[TBL] [Abstract] [Full Text] [Related]
6. Establishing reproductive potential and advances in fertility preservation techniques for XY individuals with differences in sex development.
Islam R; Lane S; Williams SA; Becker CM; Conway GS; Creighton SM
Clin Endocrinol (Oxf); 2019 Aug; 91(2):237-244. PubMed ID: 31004515
[TBL] [Abstract] [Full Text] [Related]
7. Predictive factors of recurrence in patients with early-stage epithelial ovarian cancer.
Ditto A; Leone Roberti Maggiore U; Bogani G; Martinelli F; Chiappa V; Evangelista MT; Liberale V; Ferrero S; Raspagliesi F
Int J Gynaecol Obstet; 2019 Apr; 145(1):28-33. PubMed ID: 30698271
[TBL] [Abstract] [Full Text] [Related]
8. ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer.
Montavon Sartorius C; Schoetzau A; Kettelhack H; Fink D; Hacker NF; Fedier A; Jacob F; Heinzelmann-Schwarz V
PLoS One; 2018; 13(3):e0195213. PubMed ID: 29596526
[TBL] [Abstract] [Full Text] [Related]
9. Primary extra-uterine and extra-ovarian mullerian adenosarcoma: case report and literature review.
Mandato VD; Torricelli F; Mastrofilippo V; Valli R; Aguzzoli L; La Sala GB
BMC Cancer; 2018 Feb; 18(1):134. PubMed ID: 29402239
[TBL] [Abstract] [Full Text] [Related]
10. Pelvic floor disorders in women with gynecologic malignancies: a systematic review.
Ramaseshan AS; Felton J; Roque D; Rao G; Shipper AG; Sanses TVD
Int Urogynecol J; 2018 Apr; 29(4):459-476. PubMed ID: 28929201
[TBL] [Abstract] [Full Text] [Related]
11. Fertility treatments among female cancer survivors giving birth - a Finnish register-based study.
Melin J; Madanat-Harjuoja L; Heinävaara S; Malila N; Gissler M; Tiitinen A
Acta Oncol; 2017 Aug; 56(8):1089-1093. PubMed ID: 28339338
[TBL] [Abstract] [Full Text] [Related]
12. NanoLC-MS coupling of liquid microjunction microextraction for on-tissue proteomic analysis.
Quanico J; Franck J; Cardon T; Leblanc E; Wisztorski M; Salzet M; Fournier I
Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):891-900. PubMed ID: 27836619
[TBL] [Abstract] [Full Text] [Related]
13. The Impact of Underweight Status on the Prognosis of ovarian cancer Patients: A Meta-Analysis.
Pergialiotis V; Doumouchtsis SK; Perrea D; Vlachos GD
Nutr Cancer; 2016; 68(6):918-25. PubMed ID: 27351098
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of anthropometric measurements of adiposity in relation to cancer risk: a systematic review of prospective studies.
De Ridder J; Julián-Almárcegui C; Mullee A; Rinaldi S; Van Herck K; Vicente-Rodríguez G; Huybrechts I
Cancer Causes Control; 2016 Mar; 27(3):291-300. PubMed ID: 26759333
[TBL] [Abstract] [Full Text] [Related]
15. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.
Jaaback K; Johnson N; Lawrie TA
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD005340. PubMed ID: 26755441
[TBL] [Abstract] [Full Text] [Related]
16. Hormone therapy for ovarian cancer survivors: systematic review and meta-analysis.
Pergialiotis V; Pitsouni E; Prodromidou A; Frountzas M; Perrea DN; Vlachos GD
Menopause; 2016 Mar; 23(3):335-42. PubMed ID: 26308232
[TBL] [Abstract] [Full Text] [Related]
17. Targeted Resequencing of 30 Genes Improves the Detection of Deleterious Mutations in South Indian Women with Breast and/or ovarian cancers.
Rajkumar T; Meenakumari B; Mani S; Sridevi V; Sundersingh S
Asian Pac J Cancer Prev; 2015; 16(13):5211-7. PubMed ID: 26225655
[TBL] [Abstract] [Full Text] [Related]
18. Association between MTHFR gene polymorphism and the risk of ovarian cancer: a meta-analysis of the literature.
Pu D; Jiang SW; Wu J
Curr Pharm Des; 2014; 20(11):1632-8. PubMed ID: 24720627
[TBL] [Abstract] [Full Text] [Related]
19. Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study.
Vessey M; Yeates D
Contraception; 2013 Dec; 88(6):678-83. PubMed ID: 24090961
[TBL] [Abstract] [Full Text] [Related]
20. Incidence, time trends, laterality, indications, and pathological findings of unilateral oophorectomy before menopause.
Laughlin-Tommaso SK; Stewart EA; Grossardt BR; Rocca LG; Rocca WA
Menopause; 2014 May; 21(5):442-9. PubMed ID: 24067261
[TBL] [Abstract] [Full Text] [Related]
[Next]
